BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

606 related articles for article (PubMed ID: 19155302)

  • 21. MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1.
    Tian Z; Jiang H; Liu Y; Huang Y; Xiong X; Wu H; Dai X
    Exp Cell Res; 2016 May; 343(2):135-147. PubMed ID: 27090017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.
    Yeh TS; Wang F; Chen TC; Yeh CN; Yu MC; Jan YY; Chen MF
    Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression.
    Li CH; Xu F; Chow S; Feng L; Yin D; Ng TB; Chen Y
    Eur J Cancer; 2014 Oct; 50(15):2560-9. PubMed ID: 25087183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway.
    Gu W; Li X; Wang J
    Oncol Rep; 2014 Jan; 31(1):397-404. PubMed ID: 24190507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MiR-214 inhibits cell growth in hepatocellular carcinoma through suppression of β-catenin.
    Wang X; Chen J; Li F; Lin Y; Zhang X; Lv Z; Jiang J
    Biochem Biophys Res Commun; 2012 Nov; 428(4):525-31. PubMed ID: 23068095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment.
    Yang F; Li QJ; Gong ZB; Zhou L; You N; Wang S; Li XL; Li JJ; An JZ; Wang DS; He Y; Dou KF
    Technol Cancer Res Treat; 2014 Feb; 13(1):77-86. PubMed ID: 23862748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines.
    Lin CJ; Gong HY; Tseng HC; Wang WL; Wu JL
    Biochem Biophys Res Commun; 2008 Oct; 375(3):315-20. PubMed ID: 18692484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histone lysine methyltransferase, suppressor of variegation 3-9 homolog 1, promotes hepatocellular carcinoma progression and is negatively regulated by microRNA-125b.
    Fan DN; Tsang FH; Tam AH; Au SL; Wong CC; Wei L; Lee JM; He X; Ng IO; Wong CM
    Hepatology; 2013 Feb; 57(2):637-47. PubMed ID: 22991213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.
    Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S
    FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling.
    Wang Y; Hu C; Cheng J; Chen B; Ke Q; Lv Z; Wu J; Zhou Y
    Biochem Biophys Res Commun; 2014 Apr; 446(4):1255-60. PubMed ID: 24690171
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mcl-1 is an anti-apoptotic factor for human hepatocellular carcinoma.
    Fleischer B; Schulze-Bergkamen H; Schuchmann M; Weber A; Biesterfeld S; Müller M; Krammer PH; Galle PR
    Int J Oncol; 2006 Jan; 28(1):25-32. PubMed ID: 16327976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
    Liu WH; Yeh SH; Lu CC; Yu SL; Chen HY; Lin CY; Chen DS; Chen PJ
    Gastroenterology; 2009 Feb; 136(2):683-93. PubMed ID: 19027010
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumorigenicity of cancer stem-like cells derived from hepatocarcinoma is regulated by microRNA-145.
    Jia Y; Liu H; Zhuang Q; Xu S; Yang Z; Li J; Lou J; Zhang W
    Oncol Rep; 2012 Jun; 27(6):1865-72. PubMed ID: 22378186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of Mcl-1 via RNA interference sensitizes human hepatocellular carcinoma cells towards apoptosis induction.
    Schulze-Bergkamen H; Fleischer B; Schuchmann M; Weber A; Weinmann A; Krammer PH; Galle PR
    BMC Cancer; 2006 Oct; 6():232. PubMed ID: 17014711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta.
    Tsukamoto Y; Nakada C; Noguchi T; Tanigawa M; Nguyen LT; Uchida T; Hijiya N; Matsuura K; Fujioka T; Seto M; Moriyama M
    Cancer Res; 2010 Mar; 70(6):2339-49. PubMed ID: 20215506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations.
    Ladeiro Y; Couchy G; Balabaud C; Bioulac-Sage P; Pelletier L; Rebouissou S; Zucman-Rossi J
    Hepatology; 2008 Jun; 47(6):1955-63. PubMed ID: 18433021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma.
    Shimizu S; Takehara T; Hikita H; Kodama T; Miyagi T; Hosui A; Tatsumi T; Ishida H; Noda T; Nagano H; Doki Y; Mori M; Hayashi N
    J Hepatol; 2010 May; 52(5):698-704. PubMed ID: 20347499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulfatide epigenetically regulates miR-223 and promotes the migration of human hepatocellular carcinoma cells.
    Dong YW; Wang R; Cai QQ; Qi B; Wu W; Zhang YH; Wu XZ
    J Hepatol; 2014 Apr; 60(4):792-801. PubMed ID: 24333181
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b.
    Kim JK; Noh JH; Jung KH; Eun JW; Bae HJ; Kim MG; Chang YG; Shen Q; Park WS; Lee JY; Borlak J; Nam SW
    Hepatology; 2013 Mar; 57(3):1055-67. PubMed ID: 23079745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-1 promotes apoptosis of hepatocarcinoma cells by targeting apoptosis inhibitor-5 (API-5).
    Li D; Liu Y; Li H; Peng JJ; Tan Y; Zou Q; Song XF; Du M; Yang ZH; Tan Y; Zhou JJ; Xu T; Fu ZQ; Feng JQ; Cheng P; chen T; Wei D; Su XM; Liu HY; Qi ZC; Tang LJ; Wang T; Guo X; Hu YH; Zhang T
    FEBS Lett; 2015 Jan; 589(1):68-76. PubMed ID: 25433291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.